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Pattern recognition receptors are crucial in initiating and shaping innate and adaptive immune responses and often belong to
families of structurally and evolutionarily related proteins. The human C-type lectin-like receptors encoded in the DECTIN-1
cluster within the NK gene complex contain prominent receptors with pattern recognition function, such as DECTIN-1 and LOX-
1. All members of this cluster share signiﬁcant homology and are considered to have arisen from subsequent gene duplications.
Recent developments in sequencing and the availability of comprehensive sequence data comprising many species showed that
the receptors of the DECTIN-1 cluster are not only homologous to each other but also highly conserved between species. Even
in Caenorhabditis elegans, genes displaying homology to the mammalian C-type lectin-like receptors have been detected. In this
paper, we conduct a comprehensive phylogenetic survey and give an up-to-date overview of the currently available data on the
evolutionary emergence of the DECTIN-1 cluster genes.
1.C-TypeLectin-LikeReceptors
Receptors on the surface of immune cells, which bind to
molecular patterns common to certain classes of pathogens,
such as components of bacterial or fungal cell walls, play
a crucial part in the immediate innate immune response
to these pathogens as well as in shaping and regulating
the subsequent adaptive immune response. Innate immune
signaling via pattern recognition receptors, such as the Toll-
like receptors [1], has even received media attention recently,
as the 2011 Nobel prize for medicine was awarded to Bruce
A. Beutler and Jules A. Hoﬀman “for their discoveries
concerning the activation of innate immunity” [2, 3].
Similar to the Toll-like receptors, other pattern recogni-
tion receptors such as certain C-type lectin-like receptors are
structurally and evolutionarily related members of protein
families, which have arisen from gene duplication and
expansion due to the high evolutionary pressure applied
by pathogens [4–6]. C-type lectin receptors were origi-
nally deﬁned by their carbohydrate-binding function, which
enables them to bind to complex oligosaccharides displayed
on various biological structures such as cell surfaces, cir-
culating proteins, and extracellular matrices. By binding to
these structures, C-type lectins mediate a variety of crucial
cellular processes including cell adhesion, serum glycopro-
tein turnover and quick innate-type immune responses to
potential pathogens [7]. In contrast to other animal lectins,
carbohydrate binding by these proteins was initially found to
be dependent on calcium ions; therefore this receptor family
was termed “C-type” lectins. Later it became evident that
not all family members bind to carbohydrates exclusively
and that, for some, binding might also be independent of
calcium, so the designation of C-type lectin-like receptors
was introduced [8].
One well-studied family of C-type lectin-like receptors
is encoded in the natural killer gene complex (NKC) on the
short arm of human chromosome 12 [9]. The most promi-
nent receptor family in this genomic region is the NK cell
group2(NKG2)family,whichowesitsnametoapreferential
expression on NK cells [10]. This gene cluster has been
analyzed thoroughly by our group and others [11–14], and
data available on its evolutionary development has been
reviewed previously in great detail [15].2 The Scientiﬁc World Journal
However, at the telomeric side of the NKG2 gene cluster
a subfamily of genes expressed in diﬀerent myeloid as well
as nonimmune cell types rather than on NK cells has
been identiﬁed [16, 17]. This cluster has originally been
termed myeloid cluster of the NKC [16, 17] and is now also
referredtoasDECTIN-1cluster.Itcomprisesgenesencoding
well-studied proteins like DC-associated C-type lectin-1
(DECTIN-1), lectin-like oxidized low-density lipoprotein
receptor-1 (LOX-1), C-type lectin-like receptor-1 (CLEC-1),
and CLEC-2 [18]. Recently, we and others have identiﬁed
and characterized the additional C-type lectin-like receptors
CLEC9A and CLEC12B, which belong to the DECTIN-1
subfamily of this region [19–21].
2. EvolutionoftheC-TypeLectin-LikeReceptors
of the NK Gene Complex
The C-type lectin (CLECT) motif for carbohydrate recog-
nition has emerged early during evolution. It can be found
in proteins of many model organisms, including the yeast
Saccharomyces cerevisiae, the nematode Caenorhabditis ele-
gans,andthefruitﬂyDrosophilamelanogaster [22].However,
homology between these proteins and the mammalian C-
type lectin-like receptors of the NK gene complex are
restricted to the CLECT domain (CTLD).
As shown in Figure 1, mammalian C-type lectin-like
receptors share a very speciﬁc and highly conserved common
protein structure. They are type II transmembrane proteins
and consist of a short N-terminal cytoplasmic domain, a
transmembrane region, a stalk domain providing a ﬂexible
linker between transmembrane and ligand-binding domain,
each encoded by a single exon (E1–E3), and the C-terminal
extracellular ligand-binding CTLD encoded by three exons
E4-E5. The most highly conserved feature of C-type lectin-
like receptor proteins consists of six cysteine residues which
are located in the external ligand binding domain. This high
conservation, an example of which is shown in Figure 1(b)
by an alignment of the human and the putative C. elegans
CLEC-1 protein, is accordant with the fact that these cysteine
residues are involved in intrachain disulﬁde bonds forming
the characteristic C-type lectin-like fold [23, 24], which is
crucial for ligand binding, internalization and phagocytosis
as demonstrated for LOX-1 [25]. However, it is likely that the
C. elegans protein, although termed CLEC-1, only displays
the common characteristics of C-type lectin-like receptors
and therefore might represent an ancestral progenitor of the
DECTIN-1 cluster genes, rather than being an ortholog of
one speciﬁc receptor.
Figure 2 depicts a summary of the currently available
data on the evolutionary relationship between C-type lectin-
like receptors. The evolutionary oldest species which has
been shown to possess a C-type lectin-like protein with
the above-mentioned conserved sequence characteristics is
the urochordate (sea squirt) Botryllus schlosseri, a colonial
invertebrate chordate. The protein BsCD94-1 is a type II
transmembrane receptor with a C-type lectin-like domain
with highest similarity to the mammalian C-type lectin-
like receptors natural killer receptor-p1 (NKR-P1), NKG2D,
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Figure 1: Evolutionary conserved characteristics of C-type lectin-
like receptors. (a) Schematic representation of the common
exon-intron structure of C-type lectin-like receptors and the
corresponding protein domains. N-terminal cytoplasmic domain,
transmembrane, and stalk region are each encoded by one exon, the
C-typelectin-likedomain(CTLD)bythreeexons.Disulﬁdebridged
bonds between six highly conserved cysteins in the extracellular
CTLD cause the typical β-sheet tertiary structure of C-type lectin-
like proteins. (b) Alignment of human and putative C. elegans
CLEC-1 protein sequences. Conserved CTLD cysteins are boxed in
red,asterisk(∗)fullyconserved,colon(:)stronglysimilarproperties
(>0.5GonnetPAM250matrix),period(.)weaklysimilarproperties
(>0.5 Gonnet PAM 250 matrix). Alignments were produced using
ClustalW [26]. CYT: cytoplasmic region, TM: transmembrane
region, CTLD: C-type lectin-like domain.
and CD94. Similarity to the mammalian receptors was even
higher than to previously identiﬁed soluble urochordate
lectins. The protein was named BsCD94-1, because its short
intracellular region resembles the 7-amino acid cytoplasmic
domain of mammalian CD94. Interestingly, BsCD94-1 is
expressedonasubsetofB.schlosseribloodcellsandhasarole
in allorecognition. This indicates not only that the receptor
is also conserved on a functional level, but also that these
urochordate blood cells might belong to an ancestral cell
population which represents the evolutionary origin of NK
cells [27].
The bony (cichlid) ﬁsh Oreochromis niloticus contains
C-type lectin-like genes, termed cichlid killer cell C-type
lectin-like receptors (cKLRs), that are already arranged in
a multigene cluster resembling the mammalian NK gene
complexandharboratransmembraneregion,astalkdomain
and a CTLD. Phylogenetic and protein domain analysisThe Scientiﬁc World Journal 3
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Figure 2: Evolutionary emergence of the C-type lectin-like receptors of the DECTIN-1 cluster. Schematic presentation of the evolutionary
emergence of the members of the DECTIN-1 cluster. First transmembrane C-type lectin-like receptors appear in evolutionary old species
like urochordates. However, orthologs of receptors of the DECTIN-1 cluster are restricted to mammals. Numbers indicate approximate
divergence times in million years. cKLR: cichlid killer cell C-type lectin-like receptors, NKR-P1: natural killer receptor-P1, LLT1: lectin-like
transcript-1, MHC: major histocompatibility, mya: million years ago.
reveals a close phylogenetic relationship of the cKLRs to the
receptors of the mammalian NK gene complex. However,
as for BsCD94-1 in Botryllus schlosseri, no orthology to one
particular receptor is apparent [28]. Therefore, the ﬁrst C-
type lectin-like receptor genes with expression on a putative
NK cell precursor population seem to have arisen before the
divergence of ﬁsh and tetrapods >400 million years ago with
subsequentindependentduplicationsofacommonancestral
gene [28].
The ﬁrst nonmammalian proteins with clear homology
to one speciﬁc mammalian receptor encoded in the NK gene
complex have been described in chicken (Gallus gallus). Six
C-type lectin-like NK receptor genes have been identiﬁed
within two distinct regions of the chicken genome. One
of these regions shares conserved synteny with the human
NK cell receptor complex suggesting that not only single
CTLD containing genes but the whole chromosomal region
existed already before the divergence of mammals and birds
∼300 million years ago [29–32]. Two chicken C-type lectin-
like receptors, B-NK and B-lec, have been characterized and
show the common C-type lectin-like exon-intron as well as
protein domain structure. B-NK and B-lec are most closely
related to the mammalian NKR-P1 and lectin like transcript-
1 (LLT1), respectively. Interestingly, in contrast to the NK
gene complex in mammals, which forms an entirely inde-
pendent entity from the major histocompatibility (MHC)
complex, B-NK and B-lec which comprise the whole chicken
NK gene complex are encoded within the MHC cluster,
suggestingthattheMHCcomplexandNKCshareacommon
evolutionary origin [32].
Among evolutionary older mammals, marsupial mam-
mals (opossum, Monodelphis domestica)[ 33] and mono-
tremes (platypus, Ornithorhynchus anatinus)[ 34]h a v eb e e n
shown to possess an NK gene complex. Monotremes
diverged from placental mammals 167 to 218 million years
ago [35, 36], marsupials 148 to 190 million years ago
[36, 37]. The marsupial NK gene complex is less complex
as compared to evolutionary younger mammals. However,
there are obvious orthologs to genes existing in the primate
NK gene receptor complex, such as CD69, CLEC-1B, CLEC-
1A and killer cell lectin-like receptor subfamily K, member 1
(KLRK1) coding for the NKG2D receptor [33]. In platypus
on the other hand the NK gene complex has expanded and
split into at least two regions of the genome. 213 putative
C-type lectin-like receptor genes have been identiﬁed, which
may have arisen from lineage-speciﬁc expansion. Among4 The Scientiﬁc World Journal
Table 1: Members of the DECTIN-1 cluster in diﬀerent mammalian families.
Primate Bovine Porcine Murine Canine Marsupial Monotreme
DECTIN-1     ∼ ??
LOX-1     ∼ ? ∼
CLEC-1  ∼ ?  ∼∼ ?
CLEC-2  ∼ ?  ∼∼ ?
CLEC9A  ∼ ?  ∼ ??
CLEC12B  ∼ ?  ∼ ? ∼
Existence and available information. : identiﬁedand functioncharacterized, : identiﬁed and some information published, ∼: gene/protein predicted
o n l y ,? :u n k n o w n .
these genes, orthologs of LOX-1, CD69, killer cell lectin-
like receptor-1 (KLRE-1), and CLEC12B have been identi-
ﬁed [34]. Evolutionary younger mammals, like ungulates,
rodents and nonhuman primates, share many orthologous
C-type lectin-like receptors, and syntenic regions encoding
the NK gene complex have been identiﬁed in most genomes
[38].
3.TheC-TypeLectin-LikeReceptorsof
the DECTIN-1 Cluster
The myeloid or DECTIN-1 cluster in the centromeric part
of the NK gene complex (Figure 3(a)) stands apart from
the cluster of NK receptor genes in this region. Although
homologous in sequences, the receptors of the DECTIN-1
cluster diﬀer from the receptors of the NKG2A and Ly49
family in terms of their protein expression pattern and
function in the immune system. NKG2 family members
are predominantly expressed on NK cells and a fraction of
T lymphocytes. They recognize nonclassical MHC class I
and related molecules on target cells and thereby monitor
appropriate self-MHC expression [39]. Members of the
DECTIN-1 cluster on the other hand are usually expressed
on various myeloid cells and some also on endothelial cells,
butnotonNKcellsorTlymphocytes[16].Theyhavepattern
recognition function as well as various other immune as
well as nonimmune functions. Furthermore, members of
the DECTIN-1 family are evolutionarily closer related to
each other than to members of the NK subfamily and the
encoding genes are physically separated by a longer stretch of
noncoding genomic DNA [21].
As mentioned above, the ﬁrst orthologs of DECTIN-
1 cluster genes appear together with members of the
NKG2 family in marsupial mammals (CLEC-1B, CLEC-
1A) and monotremes (LOX-1, CLEC12B) [33, 34]. Table 1
summarizes in which species DECTIN-1 cluster members
have been identiﬁed and how much information is available
about the respective receptors. Table 2 summarizes available
information on ligands and functions as well as conservation
between the receptors.
As we have shown previously [21], the DECTIN-1 cluster
is a genomic region with a high evolutionary activity in
more recent times indicated by a high AluS:AluJ ratio of
5,25:1 compared to a whole genome ratio of 3:1 [5]a s
well as a high number of evolutionary young AluY elements.
Alu sequences are abundant mobile elements propagating
through retrotransposition, and the ratio between numbers
of Alu subfamily members (AluS, AluJ, and AluY) can be
used as a measure of the evolutionary age of a speciﬁc
genomic region [40]. AluY elements were active about 24
million years ago and are therefore the most recently active
Alu repeats [41]. The AluS subfamily was active about 30
million years ago after the divergence of the primate from
the rodent lineage, whereas AluJ repeats diverged 60 million
years ago from a common source element [42]. Therefore,
the ratio between Alu elements of diﬀerent subfamilies
indicates that the DECTIN-1 cluster showed relatively recent
evolutionary activity. Despite the recent activity of Alu
sequences, the order and orientation of most genes in the
DECTIN-1 cluster seem to be preserved between human
and mouse except in a region of about 40kb containing
the CLEC-2 and CLEC12B genes (Figure 3(b)). This region
seems to be inverted in genomic sequences of primate as
compared to nonprimate mammals. Additionally, sequences
highly homologous to CLEC-2 are present in the genomic
region directly upstream of the human CLEC9A gene. This
suggests a duplication of the CLEC-2 gene followed by an
inversion of the genomic region containing the complete
CLEC-2 and CLEC12B genes in a common primate ancestor,
whichisinlineagainwithrecentevolutionarychangesinthis
area.
Whereas the C-type lectin protein motif can be found in
organisms of most evolutionary branches, C-type lectin-like
r e c e p t o r sa sd e ﬁ n e db yW e i se ta l .[ 43]s e e mt oa p p e a ro n l y
in members of the chordate phylum, including mammals,
birds,andﬁsh.However,knownorthologstoreceptorsofthe
DECTIN-1 cluster are limited to mammals.
4.DECTIN-1
DECTIN-1 has ﬁrst been described in mouse [44], but soon
after that homologs have been identiﬁed in human [16, 45],
as well as in cow [46] and pig [47]. As expected, other
p r i m a t ea sw e l la so t h e rr o d e n ts p e c i e se x p r e s sD E C T I N - 1
as well. Full-length human DECTIN-1 (isoform A) shares
72% DNA [48] and 61% protein sequence identity with
the murine receptor. The homology to the bovine protein
sequence is 74%, to the predicted chimpanzee DECTIN-1
sequence 98%, and to the canine sequence 74% (Table 2).
Since its initial discovery, DECTIN-1 has been thoroughlyThe Scientiﬁc World Journal 5
Table 2: Ligands, functions and protein sequence conservation of members of the DECTIN-1 cluster.
Ligand Function % Sequence identity to human protein
Chimp Cow Mouse Dog Platypus Opossum
DECTIN-1 β-glucan
Phagocytosis, cytokine
production, antifungal
immune defense
98 74 61 74 — —
LOX-1
Modiﬁed
lipoproteins,
apoptotic cells,
bacteria
Endocytosis, phagocytosis,
apoptosis, cytokine
production, ROS
production, implications in
vascular disease
99 73 61 74 35 —
CLEC-1 Unknown Putative regulatory
function 99 76 70 75 — 74 (CTLD only)
CLEC-2 Rhodocytin,
podoplanin
Platelet activation,
implications in tumor
metastasis,
lymphatic/blood vessel
separation during
development, phagocytosis,
cytokine production
97 69 65 70 — 74 (CTLD only)
CLEC9A Unknown ligand on
necrotic cells
Cross-presentation of
dead-cell-associated
antigens to T cells
99 71 60 72 — —
CLEC12B Unknown Putative inhibitory
function ?8 0 7 2 8 1 2 6 —
Sequence identity to the human ortholog was obtained using the NCBI HomoloGene tool (available at: http://www.ncbi.nlm.nih.gov/sites/entrez?db=
homologene).
characterized and is now well known to be a major receptor
for β-glucan, a common component of fungal cell walls. It is
expressed on myeloid cells of the innate immune system and
thereby plays a key role in innate immune defense against
fungal pathogens [49]. Upon ligand binding, intracellular
signaling via a cytoplasmic immunoreceptor tyrosine-based-
activation-motif (ITAM)-like motif recruits Syk kinase
resulting in activation of nuclear factor-κB( N F - κB),
mitogen-activatedproteinkinase(MAPK)andnuclearfactor
of activated T cells (NFAT) [50, 51].
In most species, DECTIN-1 mRNA appears in form of
twomajorsplicevariants,termedisoformAandB,whichare
the only isoforms that can bind β-glucans [46, 47, 49]. These
splice variants are translated into proteins with or without
a stalk domain, respectively, and it has been suggested that
stalkless isoform B is less eﬃcient in ligand binding and that
the use of diﬀerential isoforms might be a mechanism of
regulating cellular responses to β-glucan [52]. In addition, at
least 8 more variations of the A and B isoforms generated by
alternative splicing have been described but are predicted to
produce truncated proteins [49, 53]. Furthermore, isoform
E, which has only been identiﬁed in humans, lacks the
transmembrane region and therefore is retained in the
cytoplasm instead of being transported to the cell surface
[54].
Interestingly, DECTIN-1 has been shown to have clinical
relevance in the context of fungal infections. DECTIN-1-
deﬁcient mice showed increased susceptibility to oral can-
didiasis,withenhanceddisseminationanddecreasedsurvival
times[55].Inhumans,apolymorphismofhumanDECTIN-
1 (Y238X) with an allele frequency of 3–7% in populations
from Africa and western Eurasia has been identiﬁed. The
polymorphism causes an early-stop-codon mutation in the
DECTIN-1 CTLD, resulting in defective protein expression
a n dl a c ko fβ-glucan recognition by phagocytes leading
to impaired cytokine production. Clinically, this mutation
results in recurrent fungal infections in the carriers [56].
It has also been reported that the Y238X DECTIN-1
polymorphism is associated with increased susceptibility to
oral and gastrointestinal colonization with Candida species
in hematopoetic stem cell transplant (HSCT) recipients
[57]. Possible polymorphisms have also been identiﬁed in
other species, such as sheep, and it has been speculated
that these polymorphisms might be implicated in increased
susceptibility to fungal infections [58]. Therefore, DECTIN-
1 might not only be a relevant factor in human healthcare,
but might also have important implications for maintenance
of domestic and live stock animals.
5. LOX-1
LOX-1 was ﬁrst identiﬁed in both bovine (protein sequence
homology to human 73%) and humans [59]q u i c k l yf o l -
lowed by mouse (61%) [60]. LOX-1 homologs are now also
known to exist in pigs [61], rats [62], and rabbits [63].
Predicted sequences derived from automated computational
analysis of sequences with high homology to the human
and rodent proteins are also available for canine LOX-
1 (74% protein identity to human LOX-1). Human and
the corresponding predicted chimpanzee LOX-1 sequences6 The Scientiﬁc World Journal
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Figure 3: Organization and transcriptional orientation of the genes in the human, mouse and opossum DECTIN-1 cluster. (a) Physical
map comparing the DECTIN-1 cluster in the centromeric part of the human NK complex with the corresponding region of the mouse
and opossum NK complex, extending from the myeloid inhibitory C-type lectin-like receptor (MICL) gene to the CD94 gene. Linkage and
orientation of the genes in the myeloid cluster of the NK gene complex are depicted. (b) Possible course of events leading from the non-
primate to the primate mammalian conﬁguration of the myeloid cluster between the genes encoding MICL and CLEC-1. Modiﬁed and
reprinted with permission of John Wiley & Sons, Inc. © 2010 from [21].
share 99.3% protein identity. Strikingly, an ortholog of
human LOX-1 with a protein identity of 35% has recently
been identiﬁed in platypus (Table 2). The protein has a
predicted CTLD which contains six cystein residues [34].
However, SMART protein domain analysis fails to detect a
transmembrane region in the currently available sequences
[64].
LOX-1 has been shown to bind a variety of negatively
charged ligands, the most prominent being modiﬁed lipo-
proteins [60], aged/apoptotic cells [65] and Gram-positive
and Gram-negative bacteria [66]. Interestingly, LOX-1 lacks
classical C-type lectin-like signaling motifs, such as tyrosine
residues or transmembrane cationic amino acids [67].
Nevertheless, activation of LOX-1 upon binding to one of
its ligands has been implicated in various cellular functions,
including endocytosis, phagocytosis, apoptosis, activation
of the NF-κB pathway, and production of cytokines and
reactive oxygen species (ROS) [68–70]. An isoform of LOX-
1 generated by alternative splicing has been termed LOXIN
and was described to completely lack a ligand-binding
domain [71]. Similar to stalkless DECTIN-1, LOXIN has
been demonstrated to downmodulate LOX-1 activity by
hetero-oligomerization with the active full-length isoform.
Full-lengthLOX-1proteincanbecleavedbyaserineprotease
between Arg86-Ser87 and Lys89-Ser90 in its membrane
proximal extracellular domain and thereby sheds a soluble
form of the protein [72, 73]. To date, only CLEC-2 has beed
demonstrated to be shed by a similar mechanism [74]. LOX-
1 biology has been extensively studied because of its role in
vasculardiseaseslikeatherosclerosis,thrombosis,myocardial
ischemia reperfusion injury, hypertension as well as its
involvement in generating inﬂammatory responses during
microbial infections [69, 75]. Especially circulating levels of
solubleLOX-1(sLOX-1)inhumanserumhavebeenfoundto
be increased in inﬂammatory and atherosclerotic conditions.
They are associated with acute coronary syndrome, the
severity of coronary artery disease and with the serum levels
of biomarkers for oxidative stress and inﬂammation [76, 77].
These correlations lead to the suggestion that LOX-1 could
be used as a novel biomarker to predict vascular injury [78].
Although measurement of soluble LOX-1 may provide a
useful diagnostic tool, the endogenous function of sLOX-1
is still unclear, as preliminary data suggest that sLOX-1 does
not seem to act as an inhibitory decoy receptor [72].The Scientiﬁc World Journal 7
Clinically relevant polymorphisms of LOX-1 have also
been identiﬁed. A gene polymorphism (G501C) resulting
in a missense mutation (K167N) in the LOX-1 protein
has been associated with myocardial infarction [79]a n d
coronaryarterydisease[80].Theunderlyingmechanismwas
determined to be a decrease in ligand binding aﬃnity, lead-
ing to reduced oxidised low-density lipoprotein (ox-LDL)
binding and uptake [81]. LOX-1 polymorphisms have not
been reported in other mammals so far. However, it is likely
that similar to DECTIN-1, other species also have polymor-
phisms in LOX-1. Whether these polymorphisms turn out to
have any relevance in the context of live stock or domestic
animal health remains to be investigated.
6.CLEC-1
Expression of CLEC-1 has ﬁrst been described in humans
[16, 82] and later in rodents [21, 83]. Although poorly
characterized, CLEC-1 appears to be an important protein
judging from its high evolutionary conservation of 70 per-
cent between the human and mouse protein [84]. Opossum
possesses a minimal NK gene complex with only nine C-
type lectin-like receptor genes in total, and only CLEC-1
and CLEC-2 as members of the DECTIN-1 cluster [33, 85].
However, the available sequences contain only the gene
region encoding the CTLD of these receptors. Alignment of
these sequences to the human sequence results in a similarity
of 74%. Predicted Bos taurus and Canis familiaris CLEC-1
both share 75% similarity with the human protein sequence,
respectively (Table 2) ,a n dS M A R Tp r o t e i nd o m a i na n a l y s i s
predicts proteins with a typical C-type lectin-like domain
structure, including a CTLD, a coil-coil, and a trans-
membrane domain. However, experimental information on
corresponding proteins is still missing. Human CLEC-1
and the predicted chimpanzee protein share 99.3% identity.
Interestingly, mRNA sequencesfor aPerca ﬂavescence (yellow
perch) gene termed CLEC-1 have been generated from
whole-genome and high-throughput cDNA sequencing [86,
87]. The sequence of the Perca CLEC-1 protein aligns to
parts of both human and mouse CLEC-1 with a 17.1% score
using the ClustalW algorithm [26]; however, the similarity
to human DECTIN-1 is even slightly higher, with a score of
18.8%. A C. elegans protein also termed CLEC-1 has 12%
similarity to the human CLEC-1 protein. SMART protein
domain analysis predicts a CTLD but no transmembrane
region in both proteins. Although the available sequences are
probably only parts of corresponding full-length proteins,
sequence comparisons indicate that P. ﬂavescence and C.
elegans CLEC-1 only share the common similarities between
C-type lectin-like proteins because of the presence of the C-
type lectin-like domain. They may not be real orthologs to
human CLEC-1 but rather display the characteristics of an
ancestral progenitor of the DECTIN-1 cluster genes.
CLEC-1 still is the least well-studied member of the
DECTIN-1 family, as characterization and ligand identiﬁ-
cation proved diﬃcult due to its cellular localization which
seems to diﬀer from other family members. In our hands,
CLEC-1 could not be detected on the surface of diﬀerent
CLEC-1 expressing cells even after stimulation [88]. Also, in
contrast to other family members, CLEC-1 may have an im-
mune regulatory rather than a proinﬂammatory function, as
it has been demonstrated that in rodents and humans CLEC-
1expressionisupregulatedinresponsetoimmunoregulatory
cytokines [83, 88].
Human and rodent CLEC-1 contain one tyrosine residue
in the cytoplasmic tail close to the N-terminus which could
potentially be utilized for downstream signaling. Mouse and
rat have an additional tyrosine residue forming the ITAM-
like pattern YxxTx13YxxT [84]. However, how or whether
phosphorylation of these tyrosines occurs and leads to
downstream signaling has yet to be analyzed.
7.CLEC-2
CLEC-2 has been identiﬁed together with CLEC-1 in human
myeloid cells [16, 82], and similar to CLEC-1, the only
other species where CLEC-2 has been characterized so far is
rodents [74]. Predicted sequences derived from automated
computational analysis of sequences with high homology
to the human and rodent proteins are available for canine
and bovine CLEC-2 with 70% and 69% protein identity to
the human receptor, respectively. Interestingly, CLEC-2 does
not seem to be as highly conserved as CLEC-1 as even the
conservation between human and the predicted chimpanzee
CLEC-2 is only 96.9% as compared to 99.3% identity
between human and chimpanzee CLEC-1. As mentioned
before, opossums have a minimal NK gene complex con-
taining putative orthologs of CLEC-1 and CLEC-2 [33, 85].
Available sequences contain only the region encoding the
CTLD, and alignment of these to the human CLEC-2
sequence results in a similarity of 74% (Table 2).
CLEC-2 has been found to bind to the exogenous
ligand rhodocytin, a snake venom, [89] and the endogenous
ligand podoplanin, a protein expressed on lymphatic but not
vascular endothelium [90]. Human CLEC-2 has one YXXL
motif in its cytoplasmic tail which undergoes tyrosine phos-
phorylationbySrckinasesuponligandbinding[89].Binding
of podoplanin by CLEC-2 expressed on platelets leads
to platelet activation and has been implicated in tumor
metastasis and lymphatic/blood vessel separation during
development. Furthermore, it might also play a role in HIV
transmission [91–93]. In mice, CLEC-2 has been shown to
be expressed on neutrophils, where it mediates phagocytosis
and proinﬂammatory cytokine production [94]. In this
study, phagocytosis has been investigated using antibody-
coated beads, however the pathogens recognized and taken
up by CLEC-2, still have to be identiﬁed. Nevertheless, these
results indicate that CLEC-2, like LOX-1 and DECTIN-1,
could have innate immune pattern recognition function.
In contrast to humans which only express the full-length
CLEC-2, mice seem to have two additional splice variants.
mCLEC-2b lacks the transmembrane region, and further
deletionsinmCLEC-2ccauseaframeshiftresultinginatrun-
cated protein. As these isoforms show diﬀerent expression
patterns and subcellular localization, they might serve dif-
ferent and potentially even regulatory functions [74]. No
information about CLEC-2 polymorphisms and possible
clinical relevance is available so far.8 The Scientiﬁc World Journal
8.CLEC9A
CLEC9A is the most recently described member of the
DECTIN-1 cluster, and has been identiﬁed in human den-
dritic cells (DCs) and monocytes [19, 21]a sw e l la si nm o u s e
dendritic cells [95]. As for the other members of the family,
sequences for homologous genes have been predicted to exist
in dog (protein homology to human sequence: 72%), cattle
(71%), and chimpanzee (98.8%) (Table 2).
We have shown previously that in all primate species
analyzed, sequences highly homologous to CLEC-2 can
be found in the genomic region directly upstream of the
CLEC9A gene, and parts of the 5 -UTR sequence of the
CLEC9A mRNA are clearly derived from a duplication of an
ancestralCLEC-2sequence.However,thesesequencesdonot
seem to contribute to the CLEC9A coding sequence [21].
Human CLEC9A is translated from 6 exons and the pro-
tein is expressed at the cell surface as a glycosylated dimer. In
mice alternative splicing can generate ﬁve isoforms. One iso-
form shows the common structure of a six exon-derived C-
type lectin-like protein and has been shown to be expressed
on the cell surface as a nonglycosylated monomer [19].
In addition, a seven exon-derived isoform with an additional
exon in the CTLD, is expressed on the surface as a homod-
imer [95]. Analogous to CLEC-2, it has been speculated that
diﬀerent isoforms diﬀer in function and might even regulate
expression or protein activities.
Ligands for CLEC9A have yet to be identiﬁed. However,
signaling via CLEC9A involves its cytplasmic ITAM-like
motifandrecruitmentofSyk,similartoDECTIN-1signaling
[19]. Recently, it has been shown that CLEC9A expressed
on a subset of dendritic cells binds to an unidentiﬁed ligand
on necrotic cells and mediates cross-presentation and T-cell
responses to dead-cell-associated antigens [96].
9.CLEC12B
CLEC12B was identiﬁed in human macrophages [20], and
correspondingly mRNA is expressed in monocytic cell lines
and primary myeloid cells [21]. Sequences are available
for CLEC12b in mouse (protein homology to human se-
quence: 72%) and predicted in dog (81%) and cow (80%).
Interestingly, a putative ortholog of human CLEC12B has
been identiﬁed in platypus [34], which shares 26% identity
with human CLEC12B (Table 2). CLEC12B is unusual as it
is the only known receptor within the DECTIN-1 cluster,
which acts as an inhibitory receptor via recruitment of Src
homology phosphatase (SHP)-1 and SHP-2 [20]. We have
demonstrated that human CLEC12B has several splice vari-
ants,andmanyofthemarelikelytorenderthecorresponding
protein nonfunctional. However, as these isoforms are the
variants with the highest mRNA expression levels in most
cell types, it can also be speculated that they could still serve
af u n c t i o nd i ﬀerent from the full-length form [21].
10. Concluding Remarks
The C-type lectin protein motif can already be found in
evolutionary very old species, whereas C-type lectin-like
receptors containing the typical common protein structure
appear later in members of the chordate phylum, with repre-
sentatives identiﬁed in mammals birds, and ﬁsh. Receptors
which can be considered to be clear orthologs to speciﬁc
receptors of the DECTIN-1 cluster seem to be limited to
mammals. However, within the class of mammals, most C-
type lectin-like receptors of the DECTIN-1 cluster seem to
be highly conserved in both structure and function.
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